5UJ2 image
Deposition Date 2017-01-16
Release Date 2017-03-22
Last Version Date 2023-10-04
Entry Detail
PDB ID:
5UJ2
Title:
Crystal structure of HCV NS5B genotype 2A JFH-1 isolate with S15G E86Q E87Q C223H V321I mutations and Delta8 neta hairpoin loop deletion in complex with GS-639476 (diphsohate version of GS-9813), Mn2+ and symmetrical primer template 5'-AUAAAUUU
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.90 Å
R-Value Free:
0.22
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 65
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Genome polyprotein
Mutations:S15G E86Q E87Q C223H V321I
Chain IDs:C (auth: A)
Chain Length:572
Number of Molecules:1
Biological Source:Hepatitis C virus
Polymer Type:polyribonucleotide
Molecule:RNA (5'-R(*AP*UP*AP*AP*AP*UP*UP*U)-3')
Chain IDs:A (auth: T), B (auth: P)
Chain Length:8
Number of Molecules:2
Biological Source:Escherichia coli
Primary Citation
Discovery of a 2'-fluoro-2'-C-methyl C-nucleotide HCV polymerase inhibitor and a phosphoramidate prodrug with favorable properties.
Bioorg. Med. Chem. Lett. 27 1840 1847 (2017)
PMID: 28274633 DOI: 10.1016/j.bmcl.2017.02.037

Abstact

A series of 2'-fluorinated C-nucleosides were prepared and tested for anti-HCV activity. Among them, the triphosphate of 2'-fluoro-2'-C-methyl adenosine C-nucleoside (15) was a potent and selective inhibitor of the NS5B polymerase and maintained activity against the S282T resistance mutant. A number of phosphoramidate prodrugs were then prepared and evaluated leading to the identification of the 1-aminocyclobutane-1-carboxylic acid isopropyl ester variant (53) with favorable pharmacokinetic properties including efficient liver delivery in animals.

Legend

Protein

Chemical

Disease

Primary Citation of related structures